MedPath

Studies on pain control in musculoskeletal chronic pain diseases.

Phase 2
Recruiting
Conditions
Cervical spondylotic myelopathy, Lumbar disc herniation, Lumber spinal canal stenosis, Carpal tunnel
Cervical spondylotic myelopathy, Lumbar disc herniation, Lumber spinal canal stenosis, Carpal tunnel syndrome, Osteoarthritis od the hip, Osteoarthritis of the knee, Chronic low back pain.
Registration Number
JPRN-jRCTs031190172
Lead Sponsor
Kamiyama Masataka
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
240
Inclusion Criteria

The patients who were diagnosed with cervical spondylotic myelopathy, Lumbar disc herniation, Lumber spinal canal stenosis, Carpal tunnel syndrome, Osteoarthritis od the hip, Osteoarthritis of the knee or Chronic low back pain and his symptoms continue more than three months.
The patients who have not received medication for neurological disease with the exception of Cervical spondylotic myelopathy, Lumbar disc herniation, Lumber spinal canal stenosis, Carpal tunnel syndrome, Osteoarthritis od the hip, Osteoarthritis of the knee or Chronic low back pain and his symptoms continue more than three months.
The patients who have not received medication for a mental disorder.
The patients who have written consent to participate in this study.

Exclusion Criteria

The patients who were diagnosed with two or more in cervical spondylotic myelopathy, Lumbar disc herniation, Lumber spinal canal stenosis, Carpal tunnel syndrome, Osteoarthritis od the hip, Osteoarthritis of the knee or Chronic low back pain and his symptoms continue more than three months.
The patient who should not be administered such drugs.
The patient who should not take an MRI.
The patient who has renal dysfunction (creatinine clearance >60mL/min)
The patient who is considered by a doctor not to participate in this study.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Assessment of CNS activity
Secondary Outcome Measures
NameTimeMethod
Assessment of pain, psychology, QOL, and function.
© Copyright 2025. All Rights Reserved by MedPath